FTC sues drug middlemen for allegedly inflating insulin prices

by | Sep 20, 2024 | Consumer Products, FEATURED, HEADLINE, Investing, Stocks

The Federal Trade Commission on Friday sued three large U.S. health companies that negotiate insulin prices, arguing the drug middlemen use practices …

FEATURED